Neonatal module
1.0 Overview
The neonatal component of the MNCNH portfolio simulation is comprised of one single module. This module functions more similarly to standard vivarium simulations and is comprised of cause models, risk models, and intervention models (all of which are linked below).
2.0 Module Diagram and Data
2.1 Module Inputs
Input |
Source module |
Application |
Note |
|---|---|---|---|
Birth outcome |
Pregnancy module |
Only live births proceed through the neonatal module |
|
Gestational age |
Pregnancy module |
LBWSG risk effects |
|
Birth weight |
Pregnancy module |
LBWSG risk effects |
|
Child sex |
Pregnancy module |
Neonatal mortality rates |
|
Antenatal corticosteroid coverage |
Intrapartum intervention module |
||
RDS intervention propensity |
Initial attributes module |
Determines which simulants receive each RDS interventions (CPAP and ACS) |
|
Hemoglobin exposure at birth |
Hemoglobin module |
Affects neonatal sepsis risk |
2.2 Cause models
2.3 Risk models
The following risk factors affect neonatal causes:
Low birth weight and short gestation
Risk exposure: informed as an output from the pregnancy module
Risk effects: instructions for how to apply LBWSG risk effects are described on the Neonatal Mortality Model. Additional information can be found on the LBWSG risk effects document
Hemoglobin at end of pregnancy
Risk exposure: informed as an output from the hemoglobin module
Risk effects: affects neonatal sepsis according to the instructions on the hemoglobin risk effects document
2.4 Intervention models
Antenatal corticosteroids (coverage assumed equal to CPAP coverage, see below)
2.5: Module Outputs
See observer/outputs section on main concept model document.
3.0 Assumptions and limitations
In GBD, LBWSG impacts all-cause mortality, which overlaps with the other neonatal causes. The method for handling this is complex, since preterm birth is a PAF-of-one cause, that we want to split into preterm with and without RDS, and other causes must have a RR with LBWSG to make the all-cause RR calibrate.
In this phase of model building, we are not including lung surfactant or kangaroo care which are closely tied to the CPAP/NICU intervention. We might add these to the model in a later phase.
4.0 Verification and Validation Criteria
Confirm ACMR in sim matches ACMR in artifact
Confirm LBWSG exposure match
Confirm LBWSG RR on ACMR matches
Confirm CSMR matches for preterm, sepsis, encephalopathy
Confirm that RDS incidence and mortality match expectations
Confirm that interventions have expected efficacy and coverage rates